Cost-effectiveness of palliative emergent surgery versus endoscopic stenting for acute malignant colonic obstruction
Authors:
- 19 May 2020
- journal article
- research article
- Published by Springer Nature in Surgical Endoscopy
- Vol. 35 (5) , 2240-2247
Abstract
Background Endoscopic stenting has demonstrated value over emergent surgery as a palliative intervention for patients with acute large bowel obstruction due to advanced colorectal cancer. However, concerns regarding high reintervention rates and the risk of perforation have brought into question its cost-effectiveness. Methods A decision tree analysis was performed to analyze costs and survival in patients with unresectable or metastatic colorectal cancer who present with acute large bowel obstruction. The model was designed with two treatment arms: self-expanding metallic stent (SEMS) placement and emergent surgery. Costs were derived from medicare reimbursement rates (US$), while effectiveness was represented by quality-adjusted life years (QALYs). The primary outcome measure was the incremental cost-effectiveness ratio (ICER). The model was tested for validation using one-way, two-way, and probabilistic sensitivity analyses. Results Endoscopic stenting resulted in an average cost of $43,798.06 and 0.68 QALYs. Emergent surgery cost $5865.30 more, while only yielding 0.58 QALYs. This resulted in an ICER of − $58,653.00, indicating that SEMS placement is the dominant strategy. One-way and two-way sensitivity analyses demonstrated that emergent surgery would require an improved survival rate in comparison to endoscopic stenting to become the favored treatment modality. In 100,000 probabilistic simulations, endoscopic stenting was favored 96.3% of the time. Conclusions In patients with acute colonic obstruction in the presence of unresectable or metastatic disease, endoscopic stenting is a more cost-effective palliative intervention than emergent surgery. This recommendation would favor surgery over SEMS placement with improved surgical survival, or if the majority of patients undergoing stenting required reintervention.Keywords
This publication has 35 references indexed in Scilit:
- Outcomes of Secondary Self-Expandable Metal Stents versus Surgery after Delayed Initial Palliative Stent Failure in Malignant Colorectal ObstructionDigestion, 2013
- Palliative management for patients with subacute obstruction and stage IV unresectable rectosigmoid cancer: colostomy versus endoscopic stenting: final results of a prospective randomized trialThe American Journal of Surgery, 2012
- Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolutionCancer Management and Research, 2012
- Outcomes of secondary stent-in-stent self-expandable metal stent insertion for malignant colorectal obstructionGastrointestinal Endoscopy, 2011
- Endoscopic placement of self-expandable metal stents for malignant colonic obstruction: long-term outcomes and complication factorsGastrointestinal Endoscopy, 2010
- Colorectal stents for the management of malignant colonic obstructions2008
- Early closure of a multicenter randomized clinical trial of endoscopic stenting versus surgery for stage IV left-sided colorectal cancerEndoscopy, 2008
- Stenting or stoma creation for patients with inoperable malignant colonic obstructions? Results of a study and cost-effectiveness analysisSurgical Endoscopy, 2004
- Decision analysis in medicine.BMJ, 1992
- A convenient approximation of life expectancy (the “DEALE”)The American Journal of Medicine, 1982